 |
市場調查報告書
商品編碼
1146346
瞳孔計市場 - COVID-19 的增長、趨勢、影響和預測（2022-2027 年）Pupillometer Market - Growth, Trends, and Forecasts (2022 - 2027) |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計瞳孔計市場在預測期間（2022-2027 年）的複合年增長率為 5.1%。
COVID-19 大流行對許多國家已經不堪重負的公共衛生系統產生了巨大影響。此外，醫療保健行業的重點已轉移到流行病危機管理上。這帶來了僱用、保留和保護受過技術培訓並受到鼓勵的衛生人力的挑戰。此外，全球封鎖導致醫護人員短缺。此外，全球醫療器械供應鏈中斷。此外，瞳孔計市場在 COVID-19 大流行期間也面臨不利影響。疫情期間，眼科服務銳減。因此，這導致對瞳孔計的需求減少。
此外，冠狀病毒可以通過眼睛的結膜進入人體。因此，眼科醫生可能處於感染高風險之中。這是因為眼科醫生在檢查過程中離患者很近，使其更容易受到飛沫傳播。因此，世界衛生組織 (WHO) 已強制採取預防措施，避免眼神接觸以減少傳播。因此，世界各地的許多眼科醫生都暫時停止了執業，並發出警告。在一個國家，為眼科實踐制定了特殊指南，並暫停了實踐。例如，印度政府衛生和家庭福利部於 2020 年 12 月發布了 COVID-19 情景下的安全眼保健指南。該指南旨在最大程度地減少 COVID-19 在眼科醫護人員中的傳播。因此，收容區內的眼保健設施仍然關閉。因此，這些因素在 COVID-19 大流行期間影響了監控市場，2020 年對瞳孔計的需求下降。然而，從 2021 年開始，市場逐漸從跌勢中復蘇。這是因為醫療器械供應鏈服務已經恢復。
導致調查市場增長的主要因素包括提高與手動瞳孔成像相關的瞳孔計的意識以及技術進步。促進市場增長的其他因素包括需要使用瞳孔計的疾病流行率激增。
多年來，手動瞳孔成像一直是獲取患者瞳孔信息的主要方法。在這種傳統方法中，使用手電筒或手電筒手動評估瞳孔反應性，並使用瞳孔規來估計瞳孔大小。但是，手動瞳孔評估可能不准確且不一致。此外，可能會出現評價人之間的差異。因此，瞳孔計優於手動評估。這是因為這些光學器件在技術上具有優勢。例如，較新的瞳孔計包括紅外攝像機、LED 光源、條形碼掃描儀、支持藍牙的數據傳輸和其他高級功能。此外，條形碼掃描儀等功能消除了對外部掃描儀的需求。條形碼掃描儀等功能還消除了對外部掃描儀的需求，並避免了手動輸入患者 ID 時的轉錄錯誤。此外，市場上的新型非侵入性手持式光學掃描儀可以可靠、客觀地測量瞳孔大小、對稱性和反應性。例如，NeuroOptics 的 NPi-300 瞳孔計系統可以對瞳孔反應進行數值量化，神經瞳孔指數 (NPi) 允許對瞳孔反應進行嚴格的解釋和分類。它還提供有關瞳孔對光反射是否在正常或異常範圍內的信息。此外，您還可以查看光反射是否在非典型、不可測量或無響應範圍內。這些好處使其成為醫生的最愛。
它是視神經、腦腫瘤、視網膜、腦血管疾病和弱視中發生的不對稱的指標。當疾病或障礙以不對稱方式表現時尤其如此。因此，腦腫瘤等疾病患病率的激增導致對用於檢測腦腫瘤患者 APD 的瞳孔計的需求增加。例如，美國臨床腫瘤學會 (ASCO) 估計，到 2022 年，美國估計將有 25,050 名成年人被診斷出患有腦和脊髓原發性癌症腫瘤。
此外，神經瞳孔指數 (NPi) 測試也是必不可少的，尤其是對於患有中風、動脈瘤和心臟驟停等疾病的患者。因此，心臟驟停患病率的上升也導致對瞳孔計的需求激增，從而推動了研究市場的增長。例如，美國心臟協會發布並更新了其 2022 年的“心臟和中風統計”報告。根據該報告，美國每年發生超過 356,000 例院外心臟驟停 (OHCA)。
因此，由於上述因素，所研究的市場預計將在分析期內增長。然而，瞳孔計的高成本和專業臨床醫生的短缺影響了它們在新興國家的應用。這反過來又會影響瞳孔計市場的增長。
主要市場趨勢
預計視頻瞳孔計將在預測期內強勁增長
與數字瞳孔計相比，視頻瞳孔計更先進。例如，這些設備可以捕獲整個瞳孔活動。此外，視頻瞳孔計，例如 Konan Medical USA Inc. 的 EyeKinetix 瞳孔計，利用紅外條件下的高分辨率攝像機記錄雙側瞳孔對單眼視覺刺激的反應。此外，EyeKinetix 可以同時記錄直接和同意瞳孔對光反射。此外，近年來視頻瞳孔計的獲批也是需求激增的原因之一。例如，NeuroOptics Inc. 於 2021 年 7 月在美國推出了 NPi-300 瞳孔計。此外，NPi-300 瞳孔計配備了先進的功能，例如 LED 光源、高精度紅外攝像頭和廣泛的微處理器功能。因此，這些功能導致市場需求激增，並推動了市場的增長。
此外，與數字瞳孔計相比，NPi-300 等視頻瞳孔計是自動且快速的。這消除了其他檢查方法可能發生的人為錯誤。因此，這導致對視頻瞳孔計的需求激增，從而推動市場增長。因此，這些設備已成為臨床醫生的首選。
預計北美將主導瞳孔計市場
由於該地區有眾多提供瞳孔計的主要參與者，預計北美將主導市場。例如，在北美運營的主要參與者包括 Essilor Group (Essilor Instruments)、US Ophthalmic.、NeurOptics Inc、Konan Medical USA Inc 和 Reichert Inc.。
此外，準確的神經系統評估和瞳孔評估對於檢測創傷性腦損傷 (TBI) 患者的神經系統惡化非常重要。因此，該地區腦外傷病例激增是推動市場增長的另一個因素。此外，瞳孔計用於檢查患有視網膜疾病（例如黃斑變性、糖尿病性視網膜病變和眼內腫瘤）的患者的瞳孔反應。此外，老年人群更容易出現黃斑變性等視網膜疾病。此外，根據 BrightFocus 基金會的數據，50 至 59 歲的人患老年性黃斑變性的風險為 2%。對於 75 歲及以上的人來說，這一比例接近 30%。例如，根據2021年發布的《美國健康排名高級報告》，美國約有16.5%的人口年齡在65歲及以上。此外，預測估計預計到 2050 年，美國 65 歲及以上的總人口將增加到 8570 萬。同樣，加拿大人口老齡化加劇也是推動北美市場增長的一個因素。例如，根據加拿大政府機構加拿大統計局的數據，到 2021 年 7 月，加拿大將有 7,081,792 名 65 歲及以上的人。此外，根據人口預測，到 2025 年，老年人口可能佔人口的五分之一以上，到 2059 年將達到四分之一。因此，在美國和加拿大，越來越多的老年人患有視網膜疾病，這推動了對瞳孔計的需求增加，並推動了北美市場的增長。
因此，由於上述因素，預計北美地區的研究市場將增長。
競爭格局
由於有多家公司在全球和地區開展業務，因此瞳孔儀市場競爭激烈。在市場上運營的主要公司有NeurOptics Inc.、Essilor Group（Essilor Instruments）、Visionix、US Ophthalmic.、NIDEK SA、HAAG-STREIT GROUP、Reichert Inc、Konan Medical USA Inc、Good-Lite Company、Grobet USA（Vigor Optical）。
其他特典
- Excel 格式的市場預測 (ME) 表
- 三個月的分析師支持
內容
第 1 章介紹
- 研究假設和市場定義
- 調查範圍
第 2 章研究方法
第 3 章執行摘要
第 4 章市場動態
- 市場概覽
- 市場促進因素
- 由於技術進步，提高了對瞳孔計的認識
- 需要使用瞳孔計的疾病患病率激增
- 市場抑制因素
- 瞳孔計成本高，專家短缺
- 波特五力分析
- 新進入者的威脅
- 買方/消費者議價能力
- 供應商的議價能力
- 替代品的威脅
- 競爭公司之間的敵對關係
第 5 章市場細分（基於價值的市場規模：100 萬美元）
- 按形式
- 手持式瞳孔計
- 台式瞳孔計
- 按類型
- 數位高溫計
- 視頻瞳孔計
- 按應用
- 眼科
- 神經內科
- 其他用途
- 按最終用戶
- 醫院
- 眼科診所
- 其他最終用戶
- 按地區
- 北美
- 美國
- 加拿大
- 墨西哥
- 歐洲
- 德國
- 英國
- 法國
- 意大利
- 西班牙
- 其他歐洲地區
- 亞太地區
- 中國
- 日本
- 印度
- 澳大利亞
- 韓國
- 其他亞太地區
- 世界其他地區
- 北美
第 6 章競爭格局
- 公司簡介
- NeurOptics Inc.
- Essilor Instruments USA
- Visionix
- US Ophthalmic.
- NIDEK SA
- HAAG-STREIT GROUP
- Reichert Inc.
- Konan Medical USA Inc.
- Good-Lite Company
- Grobet USA.（Vigor Optical）
第 7 章市場機會和未來趨勢
The pupillometer market is expected to register a CAGR of 5.1% over the forecast period (2022-2027).
The COVID-19 pandemic drastically affected the already overburdened public health systems in many countries. Additionally, the core focus of the healthcare industry shifted to pandemic crisis management. This led to challenges faced in hiring, retaining, and protecting technically trained, and encouraged health professionals. Moreover, the worldwide lockdowns led to a shortage of healthcare staff. Furthermore, the supply chain of medical devices around the world was also obstructed. In addition, the pupillometer market also faced detrimental impacts during the COVID-19 pandemic. There was a sharp decline in ophthalmology services during the pandemic. Hence, this leads to a decrease in demand for pupillometers.
Furthermore, coronavirus can enter the body through the eye's conjunctiva. Hence, ophthalmologists might be at high risk of getting infected. This is because of the proximity to patients during the examination, predisposing ophthalmologists to droplet transmission. Thus, the world health organization (WHO) commissioned precautionary measures to avoid contact with the eyes to reduce transmission. Therefore, as a cautionary measure, many ophthalmologists across the world suspended their practices temporarily. In certain countries, special guidelines were laid for ophthalmology practices, and services were suspended. For instance, the Government of India Ministry of Health and Family Welfare issued guidelines on safe ophthalmology practices in the COVID-19 scenario in December 2020. These guidelines were aimed at minimizing the spread of COVID-19 among the ophthalmic healthcare staff. Hence, the Eye care facilities in containment zones remained closed. Thus, these factors led to a decline in the demand for pupillometers in the year 2020 thereby affecting the studied market during the COVID-19 pandemic. However, the market is gradually recovering from the decline since the year 2021. This is because the medical device supply chain services resumed.
The major factor leading to the growth of the studied market includes the rise in awareness associated with pupillometers over manual pupillary examination coupled with technological advancements. Other factors that contribute to the growth of the market include, the surge in the prevalence of disorders requiring the use of pupillometer.
Over the years, manual pupil assessment remained a major way of obtaining pupillary information about a patient. This conventional technique involved the usage of a penlight or flashlight to manually evaluate pupil reactivity and a pupil gauge to estimate pupil size. However, manual pupillary assessment can lead to inaccuracies and inconsistencies. Furthermore, it can result in inter-examiner variability. Hence, pupillometers are preferred over manual assessment. This is because these optical devices are technically advanced. For instance, the new pupillometers have infrared cameras, an LED light source, a barcode scanner, Bluetooth-enabled data transfer, and other advanced features. In addition, features such as the barcode scanner eliminate the need for an external scanner. Hence, this avoids any transcription errors during manual entries of a patient ID. Furthermore, the novel noninvasive, handheld optical scanners available on the market can provide reliable and objective measurements of pupillary size, symmetry, and reactivity. For instance, the NPi-300 pupillometer system offered by NeurOptics, Inc. can quantify pupil reactivity on a numeric scale, and the Neurological Pupil index (NPi) allows rigorous interpretation and classification of the pupil response. The device also delivers information on whether the pupillary light reflex falls within the normal range or abnormal range. Furthermore, the device can also check if the light reflex is in, the atypical, immeasurable, or non-reactive range. Hence, these advantages make them a preferable choice among physicians.
Afferent pupillary defect (APD) is a measure of asymmetry which may occur with the optic nerve, brain tumors, retinal, or cerebral vascular disease, and amblyopia. It occurs specifically when the disease or disorder is presenting asymmetrically. Hence, the surge in prevalence of diseases such as brain tumors leads to a rise in demand for pupillometers which are used to detect APD in patients suffering from a brain tumor. For instance, according to an estimate by the American Society of Clinical Oncology (ASCO), 25,050 adults are estimated to be diagnosed with primary cancerous tumors of the brain and spinal cord in the United States in the year 2022.
In addition, neurological pupil index (NPi) testing is essential in a patient with diseases such as stroke, aneurysm, and cardiac arrest among others. Thus, the rise in prevalence of cardiac arrest also leads to a surge in demand for pupillometers thereby driving the growth of the market studied. For instance, The American Heart Association released and updated a report "Heart and Stroke Statistics" in 2022. According to the report, each year in the United States there are more than 356,000 out-of-hospital cardiac arrests (OHCA).
Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period. However, the high cost of pupillometers and lack of specialized clinicians impacts the penetration in emerging countries. This in turn affects the growth of the pupillometer market.
Key Market Trends
Video Pupillometer is Expected to Witness High Growth Over the Forecast Period
Video pupillometers are more advanced compared to digital pupillometers. For instance, these devices can capture the entire pupillary activity. Moreover, video pupillometers such as The EyeKinetix pupillometer offered by Konan Medical USA Inc. utilize high-definition video cameras under infrared conditions to record the bilateral pupil responses to monocular visual stimuli. Furthermore, EyeKinetix simultaneously records both direct and consensual pupillary light reflexes. In addition, the recent approval of video pupillometers is another factor that leads to a surge in their demand. For instance, NeurOptics Inc. launched NPi-300 Pupillometer in the United States in July 2021. Furthermore, NPi-300 Pupillometer has advanced features such as, it includes a LED light source, a high-precision infra-red camera, and extensive microprocessor capability. Hence, these features lead to a surge in demand in the market thereby driving the growth of the market.
Furthermore, video pupillometer such as NPi-300 is automatic and quick in comparison to digital pupillometers. Hence, automatic pupillometers remove any human errors that could occur with other testing methods. Thus, this leads to a surge in demand for video pupillometers thereby driving the growth of the market. Hence, these advantages offered by them make these devices a preferred choice among clinicians.
North America is Expected to Dominate the Pupillometer Market
North America is expected to dominate the market due to the presence of a large number of key players offering pupillometers in the region. For instance, some of the key players operating in North America include Essilor Group (Essilor Instruments), US Ophthalmic., NeurOptics Inc., Konan Medical USA Inc., and Reichert Inc.
In addition, accurate neurological and pupillary assessment are critical for the detection of neurological deterioration in patients with traumatic brain injury (TBI). Hence, the surge in cases of traumatic brain injury in the region is another factor that drives the growth of the market. Furthermore, pupillometers are employed to check pupil response in patients with retinal diseases such as macular degeneration, diabetic retinopathy, intraocular tumors, and others. In addition, retinal diseases such as macular degeneration are more predisposed in the geriatric population. Moreover, according to BrightFocus Foundation, the risk of getting advanced age-related macular degeneration is 2% in people ages 50- 59. This risk is nearly 30% for those over the age of 75. For instance, according to America's Health Rankings Senior Report published in 2021, about 16.5% of the United States population is of age 65 years or above. In addition, according to the projected estimates, the total number of people aged 65 years or above is expected to rise to 85.7 million in the United States by the year 2050. Similarly, the rise in the geriatric population in Canada is also a factor that drives the growth of the market in North America. For instance, according to Statistics Canada, an agency of the Government of Canada, in July 2021, there were 7,081,792 seniors aged 65 and older in Canada. Furthermore, as per the demographic projections, senior citizens are expected to account for over one-fifth of the population by 2025 and could reach one-quarter by 2059. Thus, the rise in the geriatric population that suffers from retinal diseases in the United States and Canada drives the rise in demand for pupillometers thereby driving the growth of the market in North America.
Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the North America Region.
Competitive Landscape
The pupillometer market is competitive due to the presence of several companies operating globally as well as regionally. The key companies operating in the market are NeurOptics Inc., Essilor Group (Essilor Instruments), Visionix, US Ophthalmic., NIDEK SA, HAAG-STREIT GROUP, Reichert Inc., Konan Medical USA Inc., Good-Lite Company, and Grobet USA (Vigor Optical).
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Rise in Awareness Associated with Pupillometers Coupled with Technological Advancements
- 4.2.2 Surge in Prevalence of Disorders Requiring the Use of Pupillometer
- 4.3 Market Restraints
- 4.3.1 High Cost of Pupillometers and Lack of Specialized Clinicians
- 4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD million)
- 5.1 By Modality
- 5.1.1 Handheld Pupillometer
- 5.1.2 Table Top Pupillometer
- 5.2 By Type
- 5.2.1 Digital Pupillometer
- 5.2.2 Video Pupillometer
- 5.3 By Application
- 5.3.1 Ophthalmology
- 5.3.2 Neurology
- 5.3.3 Other Applications
- 5.4 By End User
- 5.4.1 Hospitals
- 5.4.2 Eye Clinics
- 5.4.3 Other End User
- 5.5 Geography
- 5.5.1 North America
- 5.5.1.1 United States
- 5.5.1.2 Canada
- 5.5.1.3 Mexico
- 5.5.2 Europe
- 5.5.2.1 Germany
- 5.5.2.2 United Kingdom
- 5.5.2.3 France
- 5.5.2.4 Italy
- 5.5.2.5 Spain
- 5.5.2.6 Rest of Europe
- 5.5.3 Asia-Pacific
- 5.5.3.1 China
- 5.5.3.2 Japan
- 5.5.3.3 India
- 5.5.3.4 Australia
- 5.5.3.5 South Korea
- 5.5.3.6 Rest of Asia-Pacific
- 5.5.4 Rest of the World
- 5.5.1 North America
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 NeurOptics Inc.
- 6.1.2 Essilor Instruments USA
- 6.1.3 Visionix
- 6.1.4 US Ophthalmic.
- 6.1.5 NIDEK SA
- 6.1.6 HAAG-STREIT GROUP
- 6.1.7 Reichert Inc.
- 6.1.8 Konan Medical USA Inc.
- 6.1.9 Good-Lite Company
- 6.1.10 Grobet USA. (Vigor Optical)
